Sterile Drug Products,
Expertly Delivered

With over 20 years of experience serving in pharmaceutical management positions, he successfully led the development and commercialization of multiple complex injectable products, including the Doxorubicin HCl Liposome injection. Before founding ForDoz Pharma, he was the chairman and CEO of Changzhou Jinyuan Pharmaceutical Manufacturing Co., LTD.

Deepak has over 25 years of biopharmaceutical industry experience from the early discovery phase to commercial launches. He has been integral to the success of numerous clinical programs, commercial product launches, and has held senior positions of increasing responsibilities at both small virtual (GPC Biotech and Sucampo) and large bio-pharmaceutical (Bayer and Baxter) companies. His current area of focus includes business development and general corporate strategy.

With over twenty years of experience in R&D, engineering, project management, and operations management at leading companies, Mr. Yuan has demonstrated strong leadership and crisis management abilities. He effectively managed the construction of a new cGMP sterile manufacturing facility at ForDoz and currently oversees daily operations.

Mr. Bitler has worked in the pharmaceutical industry for over thirty-five years, including 10 years of experience in manufacturing terminally sterilized and aseptically filled parenteral products, before advancing into the quality area. He led the successful FDA PAI and cGMP inspection for Doxorubicin HCl Liposome injection.

Dr. Ugwu has over 25 years of experience in complex product development, having held management positions in pharmaceutical R&D at well-known companies across the United States. He has successfully developed a variety of NDA and ANDA complex drug products, including Doxorubicin HCl Liposome injection and Abraxane.